Cactus Life Sciences Top 5 Trends of 2024

Cactus Life Sciences’ Top 5 Trends of 2024: Insights Driving Tomorrow’s MedComms

Here, we revisit our most thought-provoking articles and whitepapers, each addressing pivotal trends that influence the ever-evolving biopharma landscape...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical

This whitepaper explores the role of social media in...

Transforming Scientific Content with Microsoft 365 Copilot: Cactus Life Sciences in the Spotlight

We are thrilled to announce that Cactus Life Sciences has been featured in Microsoft Stories...
Empowering Medical Affairs by Leveraging Modular Content

Key Solution Guide: Empowering Medical Affairs by Leveraging Modular Content

In the biopharma sector, the overwhelming influx of medical data necessitates an efficient content strategy...
AI, ML, NLP, AR/VR, Blockchain in Healthcare

Emerging Technologies: Healthcare Communication Friend or Foe?

Embracing emerging technologies and innovations is not just an option but a necessity for biopharma...
plain language summaries and genAI

Readability of published vs. artificial intelligence (AI)-generated plain-language summaries (PLS)

PLS play an important role in increasing the accessibility of medical publications to a wide...
Audiovisual medical publication content and formats

Use of audiovisual data dissemination formats (ADDFs) by medical journals: then and now 

GPP 2022 guidelines endorse the use of alternative data dissemination formats, including ADDFs, to enhance...
Image - What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better

What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better?

While diverse pharma stakeholders are now consuming scientific content digitally more than ever before, the...

Learn more ABOUT our company.